To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate dehydrogenase (LDH) in predicting mortality in COVID-19-ICU-patients.
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
Montrucchio, Giorgia
;Sales, Gabriele;Rumbolo, Francesca;Palmesino, Filippo;Fanelli, Vito;Filippini, Claudia;Mengozzi, Giulio;Brazzi, Luca
2021-01-01
Abstract
To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate dehydrogenase (LDH) in predicting mortality in COVID-19-ICU-patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
141 - 2021 Effectiveness of mid-regional - Montrucchio.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
1 MB
Formato
Adobe PDF
|
1 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
